Trial initiated for long-lasting injectable PrEP to block HIV transmission
The first phase 3 clinical trial of a long-acting injectable drug to block transmission of…
The first phase 3 clinical trial of a long-acting injectable drug to block transmission of…
ViiV Healthcare, a global specialist HIV company, announced today jointly with its global partners, Vodafone…